WillItSurvive

Sells alternative consumer spending and transaction data to investment researchers.

Losing its protection
Assessed 21 July 2026 · Evidence as of 21 July 2026
The structural protection is eroding.
On the recordSince 21 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: Adoption metrics for Taurus healthcare data and Research Signal product become visible
The call

Consumer Edge has real data and real customers but sits between a Bloomberg-owned rival and AI tools that shrink the analysis layer it sells.

Consumer Edge buys credit card and healthcare records, then sells insights about what consumers are buying to hedge funds and asset managers. The problem is that Bloomberg already owns a rival called Second Measure with better distribution to traders, and artificial intelligence can now do much of the analysis work that Consumer Edge's team used to do by hand. The one thing that could matter: if their healthcare data business (called Taurus) grows into the core of the company with strong customer loyalty, it might become harder to replace than their credit card data, since healthcare records are tightly regulated and switching costs are real.

Why
01
AI pressure: Frontier research-agent models (e.g. AI systems that auto-generate analyst notes). AI can already synthesize spending trends from raw data, squeezing the analyst-insight layer Consumer Edge sells on top of its feeds. Could AI do the core job? Only partly.
02
Bigger players: Bloomberg (via Second Measure). Bloomberg bundles a rival card-data product straight into its terminal, the exact desks Consumer Edge needs to win. Could a giant copy it? Yes, easily.
03
What protects it. Licensed access to real transaction and hospital claims data that isn't easy for a new entrant to replicate or license overnight.
What would change this call
CE reports Taurus healthcare data as a named, growing share of ARR in 2026-2027. Would show the healthcare moat is real, not just a marketing bullet.
Bloomberg cuts Second Measure pricing or bundles it free with terminal subscriptions. Would show Bloomberg squeezing CE's core card-data business on price.
A major research/investment firm adopts an AI research-agent tool instead of CE's analyst notes. Would show CE's insights layer being displaced by automation.
Key numbers
  • ~$41.4M estimated annual revenue (2026)
  • 153 employees, up 16.8% year over year (June 2026)
  • ~30% ARR CAGR over prior three years (Jan 2023)
Named risks
  • Bloomberg's Terminal-distributed Second Measure compresses card-data pricing and share in core accounts. Severity: high
  • AI-driven research synthesis could compress CE's analyst-insights layer beyond raw data licensing. Severity: medium
  • Non-exclusive transaction data panels make core product commoditized against multiple substitutable peers. Severity: medium
  • Integration risk from ongoing Earnest Analytics acquisition absorption into 2026. Severity: medium
  • Data-privacy and cross-border sourcing regulatory exposure inherent to alt-data industry. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Bloomberg (Second Measure)losing toBloomberg owns Second Measure since Dec 24, 2020 with Terminal ALTD distribution CE lacks
YipitDatacontestingNamed as direct alternative-data peer competing for same investment-research clients
M SciencecontestingListed among fragmented set of alt-data competitors per CB Insights
TXN (Prosper Insights)contestingRebranded rival in consumer alt-data space, per CB Insights comparison
Questions people ask
Is Consumer Edge profitable?
No public profitability figures are disclosed. Consumer Edge reported roughly 30% organic ARR CAGR over three years as of its January 12, 2023 CoVenture raise, and third-party estimates put revenue near $41.4M, but net income has not been made public.
Who owns Consumer Edge?
Consumer Edge is privately held. Treville Capital Group has been its primary capital backer since 2022 and holds a board seat via partner Dan Bailey. CoVenture funds provided $60M+ in equity financing closed January 12, 2023, CE's first institutional raise.
Could AI replace Consumer Edge?
Partly. Consumer Edge's own June 25, 2026 Research Signal product uses proprietary modeling to replace clients' need for a dedicated data science team, showing CE is automating its analyst-insights layer, while its licensed transaction and healthcare data remain harder for generic AI to replicate.
Who is Consumer Edge's biggest competitor?
Bloomberg is the biggest structural threat, having acquired Second Measure on December 24, 2020 and distributing it through the Bloomberg Terminal's ALTD function, a distribution channel Consumer Edge cannot match. Other peers include YipitData, M Science, and TXN.
What did Consumer Edge acquire recently?
Consumer Edge completed its acquisition of Earnest Analytics on April 28, 2025, adding transaction and healthcare data capabilities as part of what the company called a new era of innovation in the alternative-data space.
What is Taurus, Consumer Edge's healthcare product?
Taurus is a hospital purchase-data product Consumer Edge launched June 11, 2026, combining hospital purchasing data with medical and pharmacy claims to expand its healthcare intelligence coverage beyond core consumer-spending data.
Timeline
  • 2026-06-25Launched Research Signal, spend-driven revenue forecasts for investors
  • 2026-06-11Launched Taurus, hospital purchase-data healthcare product
  • 2026-03-20Backer Treville closed $500M+ Capital Solutions Fund
  • 2025-04-28Completed acquisition of Earnest Analytics
  • 2025-04-14Announced agreement to acquire Earnest Analytics
  • 2023-01-12Closed $60M+ equity financing from CoVenture, first institutional raise
  • 2022Treville Capital Group begins backing Consumer Edge
  • 2020-12-24Bloomberg acquired rival Second Measure
  • 2009Founded as consumer-focused equity research boutique
Revision history
21 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources